85 related articles for article (PubMed ID: 3166484)
1. Roles of CA125 in patients with ovarian cancer--usefulness in periodical monitoring.
Kawai M; Inagaki S; Yamashita H; Imaizumi H; Kakihara M; Arii Y
Nihon Gan Chiryo Gakkai Shi; 1988 May; 23(5):1059-67. PubMed ID: 3166484
[No Abstract] [Full Text] [Related]
2. [Serum CA125 in malignant ovarian tumor--periodical monitoring and correlation with other tumor markers].
Kawai M; Yamashita H; Hayashi T; Kamiya N; Kakihara M; Arii Y
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Mar; 38(3):402-10. PubMed ID: 3457877
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors].
Suzuki M; Sekiguchi I; Tamada T; Sakurabayashi I; Kawai T
Rinsho Byori; 1985 Feb; 33(2):173-7. PubMed ID: 3858562
[No Abstract] [Full Text] [Related]
4. [Serum CA125, CA19-9 and TPA in the diagnostic approach to neoplastic pathology of the ovary].
Gadducci A; Bartolini T; Ferdeghini M; Facchini V; Bianchi R; Fioretti P
Minerva Ginecol; 1987 Sep; 39(9):601-6. PubMed ID: 3479708
[No Abstract] [Full Text] [Related]
5. [The clinical usefulness of the measurement of serum sialyl SSEA-1 antigen levels in patients with gynecologic diseases: as respects the comparative effectiveness of sialyl SSEA-1 and CA125].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):828-34. PubMed ID: 3166483
[TBL] [Abstract][Full Text] [Related]
6. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
[TBL] [Abstract][Full Text] [Related]
7. [Significance of tumor markers in the treatment of patients with ovarian malignancies].
Tomoda Y; Kano T; Furuhashi Y; Mizuno K; Kamiya N; Mizuno K; Sakakibara K; Ohta M
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3027-33. PubMed ID: 2445293
[TBL] [Abstract][Full Text] [Related]
8. [Incidence of CA 125 antigen in the blood of women with ovarian carcinoma].
Tosner J; Lacinová V; Louda B; Vanásek J
Cesk Gynekol; 1987 Nov; 52(9):681-4. PubMed ID: 3482173
[No Abstract] [Full Text] [Related]
9. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S
Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164
[TBL] [Abstract][Full Text] [Related]
10. [Clinical usefulness of tumor markers for the diagnosis of ovarian cancer].
Ito K; Udagawa Y; Nozawa S
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1964-70. PubMed ID: 1417005
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody radioimmunoassay for an antigenic determinant CA125 in ovarian cancer patients.
Lian LJ; Hu XF; Liu WS; Wu AJ
Chin Med J (Engl); 1986 Sep; 99(9):721-6. PubMed ID: 2433106
[No Abstract] [Full Text] [Related]
12. [Mucinous carcinoma-associated antigen (MCA) in ovarian cancer].
Hanzal E; Kölbl H; Gitsch G; Bieglmayer C
Gynakol Rundsch; 1990; 30 Suppl 1():68-70. PubMed ID: 2079303
[No Abstract] [Full Text] [Related]
13. [CA125 in patients with pleural effusion--in comparison with ascites patients].
Kawabe T; Hirano M; Mohri M; Sugimoto T; Nagata Y; Hisada M; Muto H; Unuma T; Momose T; Naka H
Rinsho Byori; 1987 Aug; 35(8):905-9. PubMed ID: 3480365
[No Abstract] [Full Text] [Related]
14. [Tumor markers in ovarian cancer].
Lahousen M
Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
[No Abstract] [Full Text] [Related]
15. [Relationship between tumor markers and clinical symptoms in ovarian cancer].
Yakushiji M; Nishimura H
Rinsho Byori; 1992 Apr; 40(4):354-8. PubMed ID: 1593760
[TBL] [Abstract][Full Text] [Related]
16. Tumor markers in epithelial ovarian cancer. Clinical applications.
Hempling RE
Obstet Gynecol Clin North Am; 1994 Mar; 21(1):41-61. PubMed ID: 8015766
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of immunosuppressive acidic protein (IAP), CA 125 and acute-phase proteins as parameters for ovarian cancer monitoring.
Koebl H; Tatra G; Bieglmayer C
Neoplasma; 1988; 35(2):215-20. PubMed ID: 3259680
[TBL] [Abstract][Full Text] [Related]
18. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
[TBL] [Abstract][Full Text] [Related]
19. [Clinical value of a new serum tumor marker CA602 in ovarian cancers].
Suzuki M; Sekiguchi I; Ohwada M; Aida I; Tamada T
Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1454-60. PubMed ID: 2170549
[TBL] [Abstract][Full Text] [Related]
20. [The preparation and clinical use of a radioimmunoassay CA125 kit for the diagnosis of epithelial ovarian cancer].
Liu W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Dec; 14(6):469-72. PubMed ID: 1303823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]